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ABSTRACT
We present the results of the first morphological study of a Gore® HELEX® 
Septal Occluder 30 mm that was explanted seven years after interventional 
implantation due to a significant left-to-right shunt (7 mm) which resulted 
from the stretching of the concomitant patent foramen ovale by the occluder 
after atrial septal defect closure. Complete endothelialization of the surface of 
the device, the formation of the connective tissue around the implant, minor 
chronic inflammation, the appearance of foreign body giant cells and weak-
ened myocardial cells adjacent to the implant as well as enhanced expression 
of matrix metalloproteinases were demonstrated. 
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INTRODUCTION
Percutaneous transcatheter closure of secundum atrial septal defects (ASDs) is 
an effi  cient and safe method in long-term with high procedural success rates. 
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Long-term complications are very rare which increases the importance of 
reporting them. 
Th e Gore® HELEX® occluder is composed of a single piece of nickel-tita-
nium (nitinol) wire with a patch of expanded polytetrafl uoroethylene (ePTFE) 
attached along its length. Th e elastic property of nitinol is used to form the 
wire frame into two opposing disks that bridge and close the septal defect. 
Th e ePTFE is specially designed to facilitate rapid cell penetration, thereby 
promoting rapid tissue ingrowth, resulting in permanent defect closure 
and device stability [7]. Endothelial, interstitial and infl ammatory cells that 
are located at the biomaterial interface can release various tissue media-
tors, remodel, and, even, degrade the tissue increasingly expressing matrix 
metallo proteinases (MMPs) [2]. MMPs oft en contribute to cardiovascular 
 remodeling, and enhanced MMP expression is related to the variety of patho-
logical processes and diseases, including aneurysm formation, atherosclerosis, 
myocardial infarction, hypertension, and cardiomyopathies [3]. 
MATERIALS AND METHODS
Light microscopy
Aft er surgical explantation, the device was dissected and fi xed in 10%  buff ered 
formalin. For light microscopy, the parts of the device containing only ePTFE 
without nitinol wire were dehydrated in a series of graded ethanols and 
embedded in paraffi  n. Histological sections were stained routinely with hema-
toxylin and eosin (H&E) and Masson’s trichrome. For immunohistochem-
istry, we used a panel of four anti-MMP antibodies: mouse monoclonal anti-
MMP-2 (Novocastra, Newcastle, UK, Leica Biosystems, clone 17B11, 1:40), 
anti-MMP-9 (Novocastra, Newcastle, UK, Leica Biosystems, clone 15W2, 
1:40), anti-MMP-10 (Novocastra, Newcastle, UK, Leica Biosystems, clone 5E4, 
1:25), and rabbit polyclonal anti-MMP-3 (Biorbyt, Cambridge, UK, Biorbyt 
Ltd., 1:300) antibody; mouse monoclonal anti-CD34 (Cell Marque, Rocklin, 
CA, USA, clone QBEnd/10, 1:100), anti-CD68 (DacoCytomation, Glostrup, 
Denmark, clone PG-M1, 1:50), and anti-α-smooth muscle actin (SMA) (Daco-
Cytomation, Glostrup, Denmark, clone 1A4, 1:100) antibodies. Th e antigen 
sites were visualized with 3,3’-diaminobenzidine (DAB) substrate kit (Cell 
Marque, Rocklin, CA, USA). Th e sections were counterstained with Mayer’s 
hematoxylin. Th e expression of antigens was estimated at ×100 up to ×400 
magnifi cation, using Leica light microscope (LEICA, LEITZ DMRB, Germany).
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Electron microscopy
Th e explanted device and the adjacent tissue interface were studied by a scan-
ning electron microscopy. Th e small part of the ePTFE patch and the adja-
cent cardiac tissue was fi xed in 2.5% glutaraldehyde, postfi xed in 1% OsO4, 
 dehydrated, dried by the critical point method using liquid CO2, mounted onto 
metal stub, covered with gold using an automated sputter coater (JFC-1300, 
JEOL, Japan). Finally, samples were examined under a JSM-6490LV scanning 
electron microscope (JEOL, Japan) at accelerating voltage of 10kV using SEI 
mode and magnifi cation ×1000-×4000.
CASE REPORT 
In December 2007, a 33-year-old female patient presented with complaints 
of fatigue, breathlessness on exertion and palpitations, and was admitted to 
Pauls Stradins Clinical University Hospital. Transesophageal echocardiography 
(TEE) revealed 8 mm large Ostium Secundum ASD. Additionally, a small 
patent foramen ovale (PFO) was also detected. Th e patient underwent a TEE-
guided transcatheter closure of ASD with stretched diameter of 15 mm using 
the Gore® HELEX® Septal Occluder 30 mm. Th e fi nal position of the device and 
its confi guration was stable but suboptimal with partial fl aring of the disks and 
non-signifi cant residual leak above the implant. Aft er consulting with device 
providers a decision was made to follow-up the patient. Aspirin 100 mg per day 
was started and continued for six months.
Th ere were no signifi cant shunt and the change of the device posi-
tion revealed in one month transthoracic echocardiography examination. 
Th e patient was asymptomatic and was lost of follow-up for six years until 
presented in January 2014 with exertional dyspnea, dizziness, and fatigue for 
six months. By TEE a signifi cant left -to-right shunt of 7 mm through the PFO 
resulting from the stretching of the PFO by the device was revealed. Th e device 
was explanted, and a surgical closure of interatrial communication by primary 
suture closure was performed. Postoperative echocardiography confi rmed 
immediate complete closure of ASD.
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RESULTS
Gross pathology
By gross examination, the Gore® HELEX® Septal Occluder appeared to be 
completely covered by a smooth whitish layer of tissue revealing thorough 
endothelialization. Th e nitinol frame of the device was covered only by a thin 
layer of tissue and remained visible through it. Th e wire appeared macroscopi-
cally intact and without ruptures. No thrombi or vegetations were found adja-
cent to the device.
Light microscopy, immunohistochemistry and electron microscopy
By histological examination, no fi brin deposits or evidence of acute infl am-
mation were detected. Following recommendations, published previously [4], 
the following regions of the specimen were distinguished: the outer cellular 
layer of the neoendothelium, pseudointimal connective tissue inserted 
between the neoendothelium and the device, and the neotissue represented 
by the connective tissue between the disks of the occluder. We found complete 
endothelialization of the luminal surface of the device, consisting of a single 
layer of CD34-positive endothelial cells. In turn pseudointima was identifi ed 
composing of the dense connective tissue, sparse capillaries and few spindle-
shaped fi broblast-like cells oriented parallel to the neoendothelium. Th ese cells 
were α-SMA-positive. Interestingly, because of the microporous structure of 
ePTFE, we observed deep tissue ingrowth inside the patch itself. By contrast, to 
pseudointima, the neotissue consisted of the loose connective tissue with well-
developed vascularization and abundant chaotically oriented fi broblast-like cells 
that stained positive for α-SMA. Importantly, along with the inner surface of the 
ePTFE patch, we found numerous multinucleated CD68-positive foreign body 
giant cells arranged in a single row at the cardiac tissue-device material inter-
face (Fig. 1). Additionally, minor lymphocytic and plasmacytic infi ltration was 
observed within the loose connective tissue in regions of marked angiogenesis.
Studying possible long-term eff ects of insuffi  ciently functioning occluder, 
and its associated foreign body reaction as well as remodelling of cardiac tissue 
by the estimation of MMPs we found marked expression of MMP-9 by endothe-
lium, foreign body giant cells, macrophages, fi broblasts-like cells and cardio-
myocytes (Fig. 2), whereas the expression of MMP-2, 3 and 10 was almost nil. 
Additionally, we observed extracellular MMP-9 related immunostaining in 
the dense connective tissue of the pseudointima revealing uniformly stained 
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collagen fi bers. Interestingly, that the loose connective tissue of the neotissue 
did not stain immunopositive for MMP-9 when compared to the pseudointima. 
We noted that the atrial myocardium located near the device showed 
marked morphological alteration, particular cardiomyocyte hypertrophy, the 
enlargement of nuclei and cytoplasmic myofi lament destruction. Th ese changes 
were accompanied by fi brotic tissue ingrowth into the myocardium (Fig. 3). 
Th e myocardium obtained for the ultrastructural studies consisted of diff er-
ently shaped and sized muscle cells which slightly bifurcated and connected 
Figure 1. Foreign body giant cells 
arranged in a single row at the surface 
of the occluder, H&E, ×400.
Figure 2. Marked expression of MMP-9 
by endothelium, foreign body giant cells, 
 macrophages, and fi broblast-like cells. 
Pseudointimal collagen fi bers appear to 
be densely packed and uniformly stained, 
×250.
Figure 3. Cardiomyocytes exhibiting 
MMP-9 immunopositivity. Fibrotic 
changes of the  myocardium, distortion 
of cardiomyocytes,  nuclear polymorphism 
and partial myo fi lament destruction were 
demonstrated, ×400.
Figure 4. Scanning electron microscopy 
revealing a region of myocardium demon-
strating haphazardly oriented, diff erently 
shaped and sized cardiomyocytes. The 
 content of cytoplasm includes microfi lam-
nets, mitochondria, and the endoplasmic 
reticulum, ×2000.
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with neighbouring cells, mostly at the ends of cellular trunks. Th e cytoplasm of 
cardiomyocytes revealed a varying number of microfi laments, diff erently sized 
and oriented mitochondria, and tubules of the endoplasmic reticulum (Fig. 4). 
Some cardiomyocytes showed loosening of the cytoplasmic content. 
DISCUSSION
Over the past decade, the interventional closure of amenable ASD has become 
the treatment of choice in most centers worldwide. However, very limited data 
deciphering histopathological changes and some aspects of biocompatibility 
of ASD closure devices in humans is currently available [5]. Some of these 
studies were performed on explanted the Amplatzer® Atrial Septal Defect 
Occluder that was the fi rst occlusion device to obtain approval for commer-
cialization. To date, only two devices have been approved by the US FDA with 
an indication for the transcatheter closure of ASD: the Amplatzer® Atrial Septal 
Defect Occluder (December 2001) and the Gore® HELEX® Atrial Septal Defect 
Occluder (August 2006) [5]. 
In contrast to the former, to our knowledge, there are no morphological 
studies on explanted Gore® HELEX® atrial septal defect occluder in humans, 
except for the only one study performed on dogs [7]. 
Th e major drawback of the previous histopathological studies is that 
these studies were conducted investigating a short period of implantation 
set between three months and two years aft er device implantation. Since the 
implanted devices are expected to function lifelong, it could be too little time 
to assess local tissue response and biocompatibility. In our case, the device was 
explanted seven years aft er implantation.
As was described in the previous reports of the Amplatzer® Atrial Septal 
Defect Occluder, we found foreign body giant cells located at the tissue-mate-
rial interface – a convincing evidence of a chronically persisting infl amma-
tory response [1,4,5,6]. It is supposed that foreign body giant cells can release 
various tissue remodeling mediators and lead to the degradation of several 
biomaterials with subsequent device failure [2]. Additionally, lymphocytic and 
plasmacytic infi ltration was also observed. Whether this ongoing infl ammatory 
reaction, directed against the implanted device, could result in device dysfunc-
tion or impact on its safety is unknown. To date, there are no reported adverse 
short-term and long-term eff ects of foreign body immune reaction to nitinol 
wire and ePTFE patch. 
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Biomaterial adherent macrophages can secrete a variety of proteins that 
modulate fi brosis and form a fi brous capsule around the device [2]. To study 
possible eff ects of giant cells on cardiac tissue and extracellular matrix (ECM) 
remodeling, we performed immunohistochemical analysis of the explanted 
device using antibodies to MMPs, CD34, CD68, and SMA. We found marked 
extracellular and cytoplasmic expression of MMP-9 in vascular endo thelium, 
foreign body giant cells, macrophages, fi broblasts-like cells and cardiomyo-
cytes. It is worth noting that the levels of MMPs expression were greatly 
varying. Th e expression of MMP-2, 3 and 10 was almost nil, whereas the levels 
of MMP-9 expression were high. Collagen fi bers were stained immunopositive 
in the outer dense connective tissue layer (pseudointima) but no expression 
was found in the inner loose connective tissue layer (neotissue). Th e higher 
degree of ECM remodeling in the pseudointima may subsequently lead to the 
excessive encapsulation of the device. 
Th e most striking fi nding was a morphological heterogeneity and the 
distortion of cardiomyocytes, and loosening of the cytoplasmic organelles 
including microfi laments. Additionally, fi brotic changes in the myocardium 
were also noted. Whether these alterations in the myocardium are the results of 
the enhanced MMP-9 expression and foreign body immune reaction or hemo-
dynamic characteristics attributable to the signifi cant left -to-right shunt over 
PFO, is a matter of debate. It was described previously, that enhanced MMPs 
expression could be associated with the variety of cardiovascular diseases, 
including aneurysm formation, atherosclerosis, myocardial infarction, hyper-
tension, and cardiomyopathies. However, these pathological processes were 
described for MMP-2 [3]. In our study, we found only the MMP-9 expres-
sion, which together with MMP-2 constitute the same group of gelatinases. 
According to our results, MMP-9 might have a signifi cant role in maintaining 
chronic infl ammatory response with the foreign body reaction and promoting 
fi brous encapsulation of the implanted device.
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